These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division. Villafranco JE, Lustigman AB. Food Drug Law J; 2007 Apr 10; 62(4):709-25. PubMed ID: 18557227 [No Abstract] [Full Text] [Related]
8. Ambiguities of the Dietary Supplement Health and Education Act of 1994. Pinco RG, Rubin PD. Food Drug Law J; 1996 Apr 10; 51(3):383-405. PubMed ID: 11797716 [No Abstract] [Full Text] [Related]
9. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change. Soller RW, Rice LG, Ambrose PJ. Food Drug Law J; 2007 Apr 10; 62(2):375-86. PubMed ID: 17632967 [No Abstract] [Full Text] [Related]
17. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J. Food Drug Law J; 2003 May 29; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
18. Alternative medicine--the risks of untested and unregulated remedies. Angell M, Kassirer JP. N Engl J Med; 1998 Sep 17; 339(12):839-41. PubMed ID: 9738094 [No Abstract] [Full Text] [Related]
19. The Federal Trade Commission's regulation of weight-loss advertising claims. Correia E. Food Drug Law J; 2004 Sep 17; 59(4):585-94. PubMed ID: 15875353 [No Abstract] [Full Text] [Related]
20. Billion-dollar market blossoms as botanicals take root. Glaser V. Nat Biotechnol; 1999 Jan 17; 17(1):17-8. PubMed ID: 9920256 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]